Myoguide DOC: Patient Pain Management at a Glance
Myoguide DOC: Saves Time, Increases Productivity, and Improves Communication TORONTO, April 11, 2017 – Intronix Technologies will be launching “Myoguide DOC”, a comprehensive software package designed to help clinicians who inject Botulinum Toxins, such as Botox®, Dysport® and Xeomin® to manage their patient’s spasticity and pain. Myoguide DOC is the first integrated graphics driven patient…
Read MoreMyoguide Upgraded Stimulator Capability!
December 6, 2016 –Dr. Evan Friedman, President of Intronix Technologies Corporation, announces that this will be effective as of December 15, 2016. Myoguide is a handheld injection guidance device that uses muscle signals (EMG) and stimulation, to help clinicians target the optimal site for injection of therapeutic Botox® type drugs, used for the management of muscle spasms…
Read MoreIntronix Technologies to Collaborate with Western University to Develop New Rehabilitation Technologies for Musculoskeletal Disorders
TORONTO, December 15, 2014 – Intronix Technologies will be collaborating with Western University’s Department of Electrical and Computer Engineering to develop technology to be incorporated into rehabilitation devices. Canadian-based innovator, Intronix Technologies, will be working with Dr. Ana Luisa Trejos, Assistant Professor in the Department of Electrical and Computer Engineering at Western University, and Associate…
Read MoreMyoguide at AAPM&R meeting in San Diego!
Intronix Technologies’ innovative Myoguide EMG guided injection system will be available to play with at the American Academy of Physical Medicine and Rehabilitation (AAPM&R) Annual Assembly, November 13–16, 2014 at the San Diego Convention Center. Myoguide is now available throughout Ambu’s worldwide distribution network. You can find Intronix at booth #306 and Ambu USA at…
Read MoreAmbu will be distributing Intronix Technologies' Innovative Myoguide System Worldwide
TORONTO, Oct. 27, 2014 /PRNewswire/ — Ambu, a leading global supplier of medical devices, has signed a distribution agreement with Intronix Technologies. Intronix Technologies’ innovative Myoguide EMG guided injection system will be available through Ambu’s worldwide network of distributors, which already services Ambu’s customers locally. The revolutionary Myoguide™ Needle EMG Guided Injection System has breakthrough…
Read MoreIntronix Blog
The Intronix Blog is now part of our updated website. We continue to post information as it happens. Follow us and stay informed about all things Myoguide!
Read MoreIntronix will be Attending AAPM&R Event to Share Myoguide™
Intronix will be on hand at the upcoming assembly of the American Academy of Physical Medicine and Rehabilitation (AAPM&R) to discuss the company’s most recent advance in guided injection technology.
Read MoreMyoguide Inc. Distribution for Myoguide in the USA
Myoguide distribution has just started in the USA. We are pleased to welcome Myoguide Inc. as our US division dedicated to the US market.
Read MoreMyoguide Receives an FDA 510(k)
Myoguide receives a US FDA 510(k) K111985. We are preparing to complete the process for FDA clearance and will be launching an E-Commerce section from our website. The E-Commerce system will serve US and Canadian clinicians wishing to order Myoguide directly.
Read MoreAlfred Mann Foundation
Intronix is very pleased to be providing the Myoguide to the Alfred Mann Foundation for one of their research projects.
Read MoreInformation Technology
Myoguide DOC will be coming your way very soon. The goal is to provide anatomically accurate injection site documentation, index tracking, report writing, and electronic medical records.
Read More